Author

Laura Olson

Laura Olson

Laura covers the nation's capital as a senior reporter for States Newsroom, a network of nonprofit outlets that includes New Jersey Monitor. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance.

Federal vaccine rule for private businesses to kick in on Jan. 4

By: - November 4, 2021

WASHINGTON — Many private employers beginning in January will have to ensure their workers either are fully vaccinated against COVID-19 or that they will undergo weekly testing and wear a face covering, under a new federal rule announced Thursday by the White House. The policy from the Occupational Safety and Health Administration is set to […]

COVID-19 vaccines for kids 5 to 11 get final endorsement by CDC

By: - November 2, 2021

WASHINGTON — The Centers for Disease Control and Prevention has signed off on giving Pfizer’s COVID-19 vaccine to all kids ages 5 to 11, a final decision that means those children can begin receiving shots as soon as Wednesday. Vials of the pediatric version of the vaccine have already been shipped to states, so they are […]

Shipments of COVID-19 shots for kids 5-11 on the way to states after FDA gives green light

By: - October 29, 2021

WASHINGTON — Regulators at the U.S. Food and Drug Administration on Friday granted emergency authorization to Pfizer’s COVID-19 vaccine for 5- to 11-year-olds, a step that means kid-sized doses can begin shipping to health care providers across the country.  Vials of the two-shot vaccine will be headed to pediatricians’ offices, hospitals, pharmacies and other providers, so […]

What’s in—and out—of Biden’s $1.75 trillion social spending and climate bill

By: and - October 29, 2021

WASHINGTON — President Joe Biden’s sprawling social spending and climate package has been slimmed down into a still-massive $1.75 trillion plan that he and top congressional Democrats are attempting to wrestle through after months of negotiations. Snipped from that proposal are a number of key priorities for Democrats, including an attempt to create the first […]

FDA panel recommends OK for Pfizer’s vaccine for kids 5 to 11

By: - October 26, 2021

WASHINGTON — A federal vaccine advisory panel on Tuesday recommended authorizing Pfizer’s COVID-19 vaccine for children ages 5 to 11, a decision that means as soon as next week everyone in the U.S. over age 5 is expected to be eligible for a shot. The vote by the Food & Drug Administration panel, with 17 […]

COVID-19 vaccines for kids ages 5 to 11 could be ready as soon as next week

By: - October 26, 2021

WASHINGTON — The next wave of the massive COVID-19 vaccination campaign could begin as soon as next week, after federal regulators decide if elementary school students across the U.S. should begin rolling up their tiny sleeves. That multistep approval process kicks off Tuesday, when the Food & Drug Administration’s panel of vaccine experts will vote on […]

Feds OK ‘mix-and-match’ approach for COVID-19 booster shots

By: - October 20, 2021

WASHINGTON — The U.S. Food and Drug Administration has given a green light to Americans who want to receive a booster dose of a COVID-19 vaccine manufactured by a different company than the one that produced the initial shot they received. The announcement Wednesday on allowing “mix-and-match” shots from different manufacturers will give more flexibility to […]

Kids age 5 to 11 next in line for COVID-19 vaccines as White House rolls out plans

By: - October 20, 2021

WASHINGTON — Smaller needles. Redesigned shipments to ease the storage needs in pediatricians’ offices. And enough vials of the COVID-19 vaccine to inoculate the 28 million U.S. children between ages 5 and 11. Those are among the plans announced by the White House on Wednesday as federal and state officials prepare for a regulatory decision […]

Booster shot of Johnson & Johnson COVID-19 vaccine recommended by FDA panel

By: - October 15, 2021

WASHINGTON — A federal vaccine advisory panel on Friday endorsed a second dose of Johnson & Johnson’s one-shot COVID-19 vaccine, meaning millions more Americans are expected to soon join the line for booster shots. Anyone who received a J&J shot at least two months ago will be eligible for an additional dose, under the committee’s […]

FDA panel recommends booster shot of Moderna’s COVID-19 vaccine

By: - October 15, 2021

WASHINGTON — Millions of Americans who received Moderna’s two-shot COVID-19 vaccine are expected to be eligible soon for booster shots, after a federal advisory panel on Thursday recommended a third dose for older and higher-risk adults as well as certain workers. The unanimous recommendation from the Food and Drug Administration vaccine panel came a few […]

Misinformation abounds as U.S. House panel questions Arizona’s presidential election ‘audit’

By: - October 7, 2021

WASHINGTON — It didn’t take long for Thursday’s congressional hearing about a controversial ballot review in Arizona to demonstrate the persistent misinformation about the validity of last year’s presidential election. Rep. Jamie Raskin, a Maryland Democrat, asked his colleague, Arizona Republican Andy Biggs, if he accepts the findings of the GOP-led review of ballots in Maricopa […]

Why there’s such an impasse in Congress: Some questions and answers

By: and - October 4, 2021

WASHINGTON — Congress may have kept the federal government operating with an 11th-hour flurry of votes on Thursday, but several key pieces of the Democratic agenda remain in limbo. Here are some questions and answers on where negotiations stand with two massive Democratic-drafted bills — and the status of other looming challenges for federal lawmakers:  President […]